Last reviewed · How we verify
S-3304
At a glance
| Generic name | S-3304 |
|---|---|
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer (PHASE1, PHASE2)
- A Phase 1 Study of S-3304 in Patients With Solid Tumors (PHASE1)
- S-3304 in Treating Patients With Advanced Solid Tumors (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- S-3304 CI brief — competitive landscape report
- S-3304 updates RSS · CI watch RSS